Search for new factors involved in glycolipid metabolism and transport by a genome-wide shRNA screen
| Project/Area Number |
26440069
|
|---|
| Research Category |
Grant-in-Aid for Scientific Research (C)
|
| Allocation Type | Multi-year Fund |
|---|
| Section | 一般 |
|---|
| Research Field |
Functional biochemistry
|
|---|
| Research Institution | National Institute of Infectious Diseases |
|---|
Principal Investigator |
|
|---|
| Project Period (FY) |
2014-04-01 – 2017-03-31
|
| Project Status |
Completed (Fiscal Year 2016)
|
| Budget Amount *help |
¥4,940,000 (Direct Cost: ¥3,800,000、Indirect Cost: ¥1,140,000)
Fiscal Year 2016: ¥1,560,000 (Direct Cost: ¥1,200,000、Indirect Cost: ¥360,000)
Fiscal Year 2015: ¥1,560,000 (Direct Cost: ¥1,200,000、Indirect Cost: ¥360,000)
Fiscal Year 2014: ¥1,820,000 (Direct Cost: ¥1,400,000、Indirect Cost: ¥420,000)
|
|---|
| Keywords | スフィンゴ糖脂質 / 志賀毒素 / ゲノムワイドスクリーニング / shRNA / ゲノム編集法 / 遺伝子編集法 |
|---|
| Outline of Final Research Achievements |
In this study, a genome-wide shRNA screen was performed using Shiga toxin (Stx)-induced cell death to search for new factors that are involved in glycolipid metabolism and transport. Several genes essential for the biosynthesis of Gb3, the Shiga-toxin receptor, were concentrated, which included glucosylceramide synthase. Furthermore, many shRNAs were concentrated in this screen. However, most of the Stx-resistant shRNAs showed off-target effects, which included an shRNA targeted for CERS2, one of the ceramide synthases. Then, CERS2 mutants were constructed by genome-editing, and non-resistance to Stx was confirmed in these mutants. On the other hand, sphingolipid biosynthesis was analyzed in these mutants, and the results suggested the existence of a yet-to-be-identified mechanism rendering very-long-chain-ceramides more accessible than C16-ceramide to glucosylceramide synthase, compared with sphingomyelin synthase.
|
Report
(4 results)
Research Products
(13 results)
